Digestive Diseases and Sciences

, Volume 59, Issue 10, pp 2488–2496 | Cite as

GERD Symptoms in the General Population: Prevalence and Severity Versus Care-Seeking Patients

  • Erica Cohen
  • Roger Bolus
  • Dinesh Khanna
  • Ron D. Hays
  • Lin Chang
  • Gil Y. Melmed
  • Puja Khanna
  • Brennan Spiegel
Original Article

Abstract

Background

Prior estimates suggest that up to 40 % of the US general population (GP) report symptoms of gastroesophageal reflux disease (GERD). However, symptoms in the GP versus patients seeking care for gastrointestinal (GI) complaints have not been compared. We estimated the prevalence and severity of GERD symptoms in the GP versus GI patients, and identified predictors of GERD severity. We hypothesized that similar to functional GI disorders, psychosocial factors would predict symptom severity in GERD as much, or perhaps more, than care-seeking behavior alone.

Methods

We compared the prevalence of heartburn and regurgitation between a sample from the US GP and patients seeking GI specialty care. We compared GERD severity between groups using the NIH PROMIS® GERD scale. We then performed multivariable regression to identify predictors of GERD severity.

Results

There was no difference in the prevalence of heartburn between the GP and patient groups (59 vs. 59 %), but regurgitation was more common in patients versus GP (46 vs. 39 %; p = 0.004). In multivariable regression, having high visceral anxiety (p < 0.001) and being divorced or separated (p = 0.006) were associated with higher GERD severity.

Conclusions

More than half of a GP sample reports heartburn—higher than previous series and no different from GI patients. Although regurgitation was more prevalent in patients versus the GP, there was no difference in GERD severity between groups after adjusting for other factors; care seeking in GERD appears related to factors beyond symptoms, including visceral anxiety.

Keywords

Gastroesophageal reflux disease Patient-reported outcomes Symptoms 

Abbreviations

GI

Gastrointestinal

PRO

Patient-reported outcome

HRQOL

Health-related quality of life

PROMIS

Patient-Reported Outcome Measurement Information System

Notes

Acknowledgments

NIH/NIAMS U01 AR057936A, the National Institutes of Health through the NIH Roadmap for Medical Research Grant (AR052177). Puja Khanna was supported by Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant NIAMS 1 T32 AR053463 and ACR Research and Education Foundation Clinical Investigator Fellowship Award 2009_11. Dinesh Khanna was also supported by NIAMS K24 AR063120. Ron Hays was also supported by NIH/NIA Grants P30-AG028748 and P30-AG021684, and NCMHD Grant 2P20MD000182. Lin Chang was also supported by NIDDK P50 DK64539.

Conflict of interest

Brennan Spiegel has received grant support from Ironwood, Amgen, and Shire Pharmaceuticals, and served as a consultant to Ironwood, Forest, and Takeda North America. Dinesh Khanna has served as consultant and/or received grant support from Actelion, Astra-Zeneca, Bayer, BMS, DIGNA, Genentech, Gilead, InterMune, Merck, Takeda, Savient, and United Therapeutics. Ron D. Hays has served as a consultant to Amgen, Allergan, Pfizer, and the Critical Path Institute. Gil Melmed has served as a consultant for Abbvie and Jannsen, is on the speaker’s bureau for Prometheus and Abbott, and has received research support from Pfizer. Lin Chang has served as a consultant to Ironwood, Forest, Prometheus, Salix, Takeda North America and has received grant support from Shire and Ironwood.

References

  1. 1.
    Tack J, Becher A, Mulligan C, et al. Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life. Aliment Pharmacol Ther. 2012;35:1257–1266.PubMedCrossRefGoogle Scholar
  2. 2.
    Becher A, El-Serag H. Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34:618–627.PubMedCrossRefGoogle Scholar
  3. 3.
    El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007;5:17–26.PubMedCrossRefGoogle Scholar
  4. 4.
    A Gallup survey on heartburn across America. Princeton, NJ: The Gallup Organization, Inc., 1988.Google Scholar
  5. 5.
    Agreus L, Svardsudd K, Talley NJ, et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol. 2001;96:2905–2914.PubMedCrossRefGoogle Scholar
  6. 6.
    Fedorak RN, Veldhuyzen van Zanten S, Bridges R. Canadian Digestive Health Foundation public impact series: gastroesophageal reflux disease in Canada: incidence, prevalence, and direct and indirect economic impact. Can J Gastroenterol. 2010;24:431–434.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Frank L, Kleinman L, Ganoczy D, et al. Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life. Dig Dis Sci. 2000;45:809–818.PubMedCrossRefGoogle Scholar
  8. 8.
    Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–717.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143:1179e1-3–1187e1-3.CrossRefGoogle Scholar
  10. 10.
    Camilleri M, Dubois D, Coulie B, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005;3:543–552.PubMedCrossRefGoogle Scholar
  11. 11.
    Locke GR 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448–1456.PubMedCrossRefGoogle Scholar
  12. 12.
    El-Serag H, Hill C, Jones R. Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database. Aliment Pharmacol Ther. 2009;29:470–480.PubMedCrossRefGoogle Scholar
  13. 13.
    Bretagne JF, Honnorat C, Richard-Molard B, et al. Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms. Aliment Pharmacol Ther. 2006;23:607–616.PubMedCrossRefGoogle Scholar
  14. 14.
    Solmaz M, Kavuk I, Sayar K. Psychological factors in the irritable bowel syndrome. Eur J Med Res. 2003;8:549–556.PubMedGoogle Scholar
  15. 15.
    Van Oudenhove L, Aziz Q. The role of psychosocial factors and psychiatric disorders in functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013;10:158–167.PubMedCrossRefGoogle Scholar
  16. 16.
    Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007;45:S3–S11.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Spiegel BM. Patient-reported outcomes in gastroenterology: clinical and research applications. J Neurogastroenterol Motil. 2013;19:137–148.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Spiegel B, Hays RD, Bolus R, et al. Development of the NIH Patient Reported Outcomes Measurement Information System (PROMIS®) Gastrointestinal Symptom Scales. Am J Gastroenterol. 2014 (in press).Google Scholar
  19. 19.
    Labus JS, Bolus R, Chang L, et al. The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther. 2004;20:89–97.PubMedCrossRefGoogle Scholar
  20. 20.
    Labus JS, Mayer EA, Chang L, et al. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index. Psychosom Med. 2007;69:89–98.PubMedCrossRefGoogle Scholar
  21. 21.
    Revicki DA, Wood M, Wiklund I, et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998;7:75–83.PubMedCrossRefGoogle Scholar
  22. 22.
    DeWalt DA, Rothrock N, Yount S, et al. Evaluation of item candidates: the PROMIS qualitative item review. Med Care. 2007;45:S12–S21.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Spiegel B, Khanna D, Bolus R, et al. Understanding gastrointestinal distress: a framework for clinical practice. Am J Gastroenterol. 2011;106:380–385.Google Scholar
  24. 24.
    Baker LH, Lieberman D, Oehlke M. Psychological distress in patients with gastroesophageal reflux disease. Am J Gastroenterol. 1995;90:1797–1803.PubMedGoogle Scholar
  25. 25.
    Wong RK, Drossman DA, Weinland SR, et al. Partner burden in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013;11:151–155.PubMedCrossRefGoogle Scholar
  26. 26.
    Spiegel BM. Burden of illness in irritable bowel syndrome: looking beyond the patient. Clin Gastroenterol Hepatol. 2013;11:156–157.PubMedCrossRefGoogle Scholar
  27. 27.
    Naliboff BD, Mayer M, Fass R, et al. The effect of life stress on symptoms of heartburn. Psychosom Med. 2004;66:426–434.PubMedCrossRefGoogle Scholar
  28. 28.
    Delaney B. Prevalence and epidemiology of gastro-esophageal reflux disease. Aliment Pharmacol Ther. 2004;20:2–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992;102:1259–1268.PubMedGoogle Scholar
  30. 30.
    El-Serag HB, Petersen NJ, Carter J, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004;126:1692–1699.PubMedCrossRefGoogle Scholar
  31. 31.
    Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142–146.PubMedCrossRefGoogle Scholar
  32. 32.
    van Soest EM, Dieleman JP, Siersema PD, et al. Increasing incidence of Barrett’s oesophagus in the general population. Gut. 2005;54:1062–1066.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Locke GR, 3rd, Talley NJ, Fett SL, et al. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106:642–649.Google Scholar

Copyright information

© Springer Science+Business Media New York (Outside the USA) 2014

Authors and Affiliations

  • Erica Cohen
    • 1
    • 6
  • Roger Bolus
    • 2
    • 8
  • Dinesh Khanna
    • 3
  • Ron D. Hays
    • 4
    • 5
  • Lin Chang
    • 2
    • 7
  • Gil Y. Melmed
    • 6
  • Puja Khanna
    • 3
  • Brennan Spiegel
    • 1
    • 2
    • 8
  1. 1.Department of GastroenterologyVA Greater Los Angeles Healthcare SystemLos AngelesUSA
  2. 2.Division of Digestive DiseasesDavid Geffen School of Medicine at UCLALos AngelesUSA
  3. 3.Division of RheumatologyUniversity of MichiganAnn ArborUSA
  4. 4.Division of General Internal Medicine and Health Services ResearchDavid Geffen School of Medicine at UCLALos AngelesUSA
  5. 5.Department of Health ServicesUCLA School of Public HealthLos AngelesUSA
  6. 6.Department of GastroenterologyCedars-Sinai Medical CenterWest HollywoodUSA
  7. 7.Center for Neurobiology of StressDavid Geffen School of Medicine at UCLALos AngelesUSA
  8. 8.UCLA/VA Center for Outcomes Research and EducationLos AngelesUSA

Personalised recommendations